default author photo

Vishal Goyal

Drugs for Neglected Diseases Initiative (DNDi)

Geneva, Geneva

Switzerland

SCHOLARLY PAPERS

1

DOWNLOADS

67

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial

Number of pages: 28 Posted: 08 Dec 2020
Drugs for Neglected Diseases Initiative (DNDi), Selayang Hospital - Department of Hepatology, Ministry of Public Health - Department of Disease Control, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Chiang Mai University - PHPT/IRD, Hospital Ampang - Department of Medicine/Gastroenterology, Hospital Sultanah Bahiyah - Department of Medicine/Gastroenterology, Hospital Selayang - Department of Hepatology, Hospital Tengku Ampuan Afzan - Department of Medicine/Gastroenterology, University of Malaya (UM) - Gastroenterology and Hepatology Unit, Hospital Sungai Buloh - Department of Medicine/Infectious Disease, Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Nakornping Hospital, Thai Red Cross AIDS Research Centre, Bangkok, Bamrasnaradura Infectious Diseases Institute, Geneva University Hospitals and Faculty of Medicine - Laboratory of Virology, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi) and Ministry of Health Malaysia
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...